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Abstract 
Single-Case experimental designs (SCED) are experimental designs aiming at testing the effect of an 
intervention using a small number of patients (typically one to three), using repeated measurements, 
sequential (± randomized) introduction of an intervention and method-specific data analysis, 
including visual analysis and specific statistics. The aim of this paper is to familiarise professionals 
working in different fields of rehabilitation with SCEDs and provide practical advice on how to design 
and implement a SCED in clinical rehabilitation practice. Research questions suitable for SCEDs and 
the different types of SCEDs (e.g., alternating treatment designs, introduction/withdrawal designs 
and multiple baseline designs) are reviewed. Practical steps in preparing a SCED design are outlined. 
Examples from different rehabilitation domains are provided throughout the paper. Challenging 
issues such as the choice of the repeated measure, assessment of generalisation, randomization, 
procedural fidelity, replication and generalizability of findings are discussed. Simple rules and 
resources for data analysis are presented. The utility of SCEDs in physical and rehabilitation medicine 
(PRM) are discussed. 
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Introduction 
What are SCEDs? 
The term Single-Case Experimental Designs (SCEDs) refers to a set of experimental methods that can 
be used to test the efficacy of an intervention using a small number of patients (typically one to 
three), and involve repeated measurements, sequential (± randomized) introduction of an 
intervention, specific data analysis and statistics. SCEDs are not case reports but studies carefully 
designed prior to the start of an intervention and are therefore truly “experimental” designs. 
Different names have been given to SCEDs (see column 1 of table 1), and many different types of 
SCEDs have been used in the literature (see column 2 of table 1), which will be described later in this 
paper. Regardless of the terminology, the design framework is essentially the same: (1) studying 
prospectively and intensively a single person or small group of persons over time, (2) measuring 
repeatedly and frequently the outcome in all phases of the study, and (3) sequentially applying 
and/or withdrawing the intervention(1). What distinguishes SCEDs from group designs is that 
individual behavior is repeatedly measured both in the absence and presence of a specified 
intervention. These repeated measures allow patients and participants to serve as their own controls 
by reflecting each individual’s performance at baseline (i.e. before the intervention is introduced), 
then with intervention. Individuals are studied during multiple discrete phases—at minimum two 
phases, generally baseline (by convention designated with the letter, A) and treatment or 
intervention phase (designated with the letter, B) (2). 
INSERT TABLE 1 
SCEDs have been used for 50 years, especially in the field of education and psychology. In the 
medical setting, the term “N-of-1 trial” arose in the mid-1980s in response to limitations that were 
apparent in applying the findings of randomized controlled trials (RCTs) to the individual patient 
when making treatment decisions(3). In psychology, SCEDs have a long history of use in the 
evaluation of behavior management interventions and in the context of learning disability, whilst in 
rehabilitation, most SCED papers examine cognitive interventions (especially in aphasiology, 
neuropsychological rehabilitation and special education) with a number of tutorials and didactic 
papers presenting SCED use in cognitive rehabilitation and behavioral interventions (4–6). 
Introductory papers on SCEDs and reviews have been published in motor areas as well, such as 
sports(7), adapted physical activity(8) and domains important to rehabilitation such as pain 
treatments(9); technology-based health interventions (10); music therapy (11). Graham, Karmarkar 
and Ottenbacher wrote an excellent special communication presenting SCED use across numerous 
fields of rehabilitation (1).  
A recent resurgence of interest in SCEDs has been noted by Smith(12) and by Tate(2), and is reflected 
in a number of journal special issues on SCEDs, including in rehabilitation journals (Aphasiology 
Volume 29, 2015, Issue 5; Neuropsychological Rehabilitation 2014, 42; Evidence-Based 
Communication Assessment and Intervention (Volume 2, Issue 3) in 2008, Remedial and Special 
Education (Volume 34, Issue 1) in 2013). Evans et al.(13) identified three possible reasons for this 
recent resurgence: 
-the Oxford Centre for Evidence-Based Medicine (www.cebm.net) now rank the randomised N-of-1 
trial as Level 1 evidence for treatment decision purposes in individual patients, alongside systematic 
reviews of RCTs . 
- the development of quality assessment tools and reporting guidelines, aimed at improving the 
methodological quality, and consistency in reporting, of SCEDs. 
- the development of methods of analysis suitable for SCED data. 
 
SCEDs enable high quality research with small numbers of patients, in the clinical setting, in 
populations that are small, too heterogeneous, or too atypical to constitute a group in RCTs. They 
allow an intervention to be tailored to the unique needs of a patient, and to assess its effectiveness 
through a rigorous methodology. Because one to three subjects are sufficient to draw reliable 
conclusions, SCEDs are less influenced by recruitment problems. They have, therefore, a lower risk of 
type 2 error, often caused in group studies by insufficient number of included subjects(14) -in SCEDs 
power comes from the number of repeated measures and not from the number of patients. Studying 
less subjects but more intensely and comprehensively allows insight into intervention mediating 
effects and better knowledge of the studied subjects (15). Furthermore, SCEDs can detect an 
intervention effect within the (often large) variability of a subject’s performance (due to pain, fatigue 
etc.). RCTs on the other hand, measure a patient’s performance a limited number of times (most 
often: pre, post and at follow-up) and have a risk of obtaining a score that is not representative of 
the individual (e.g. if the patient was particularly in pain/tired on the day of the evaluation). 
Compiling a list of advantages in using SCEDs is beyond the aim of this paper; readers can refer to 
excellent papers (1,6,16–18) that comprehensively outline the numerous positive aspects of SCED 
methodology. 
Aim of the paper 
The aim of this paper is to familiarise professionals working in all fields of rehabilitation with SCED 
methodology and provide practical advice on how to design and implement a SCED in clinical 
rehabilitation practice. It does not aim to be an exhaustive tutorial on SCEDs, but rather to be a 
practical guide for clinicians who are beginners in SCEDs wishing to use this methodology in their 
daily practice. 
When to use SCED methodology 
SCED methodology aims to test the effectiveness of an intervention or to compare the relative 
effectiveness of two or more interventions. « In general, small-N designs (i.e. SCEDs) are practical 
complements to larger N trials. They can be useful in the early developmental phase of research as 
well as in refining the application of research findings to individual patients. » (p s115)(1) 
 
Situations that particularly lend themselves to SCEDs are: (1)Evaluating the efficacy of a current 
intervention for one particular patient in daily clinical practice to provide the best treatment based 
on evidence rather than clinical impressions. (2)Conducting research in a clinical rehabilitation setting 
(outside a research team) with a single or few patients (3)Piloting a novel intervention, or 
application/modification of a known intervention to an atypical case or other condition/type of 
patients that the intervention was originally designed for. (4)Investigating which part of an 
intervention package is effective. (5)Working with rare conditions or unusual target of intervention, 
for which there would never be enough patients for a group study. (6)Impossibility to obtain a 
homogenous sample of patients for a group study. (7)Time limitation (e.g. a study needing to be 
completed within 8 months, e.g. for a master degree research…) or limited funding not allowing 
recruitment of a group. 
 
Having decided that a SCEDs is, in principle, appropriate and preferable to a group design, the next 
questions is whether a SCED is feasible? The main reasons that may prevent use of a SCED is the 
difficulty in choosing a valid and reliable outcome measure that can be measured repeatedly. 
Repeated outcome measures in SCEDs 
One of the most challenging aspect of SCED methodology is finding an adequate outcome measure 
to assess intervention effectiveness. Contrary to group trials and clinical practice where norm-
references, standardized tests of known clinimetrics are used, SCED methodology usually requires 
the clinician to create an outcome measure that is relevant to the function being addressed, 
specifically for the patient and for the intervention being tested that can be assessed reliably 
multiple times. 
Table 2 gives the differences in outcome measures between group studies and SCEDs 
INSERT TABLE 2 
 
Following behavioral sciences literature, the primary outcome measure in SCED methodology is 
referred to as the “target behavior” This variable is measured repetitively in baseline(s) and 
intervention phase(s) and is therefore also simply called the “repeated measure” or the “target 
variable”. The SCRIBE (Single-Case Reporting guideline In Behavioural Interventions) statement(19) 
provides the following recommendation on the target variable: (1)Target behaviours should be: 
“relevant to the behavior in question and that best match the intervention, as well as accurate in 
their measurement”. (2)In order to enhance quality of the study and minimize bias: they should be 
specific, observable and replicable (p20)(19) (Barlow et al., 2009). (3)“Because the target behaviours 
are highly specific to the presenting case in SCEDs, formal psychometric evaluation of the measures 
will generally not have been established. It is therefore recommended practice that evaluation of 
inter-observer agreement on the target behavior is conducted and reported.”(19).  
 
Although it may seem at first extremely challenging to find an outcome measure that fulfils the 
above requirements, the rehabilitation literature has shown great creativity in the repeated outcome 
measures used. Examples from different rehabilitation domains are provided in table 3. 
INSERT TABLE 3 
There are three main ways of acquiring the repeated measures : (1) independently of intervention 
sessions (e.g. in an intervention consisting of a weekly one-hour rehabilitation session, the repeated 
measures consisted of text messages sent by patients three times a week outside the rehabilitation 
centre(20)), (2) during each intervention sessions (e.g. : number of correctly named verbs at the end 
of each speech therapy session(21)) ; (3) during the intervention session, but on some intervention 
days only (e.g. once a week during a daily intervention). This last option is preferable to the second 
option when (a) the intervention is expected to show slow changes; (b) the intervention is intensive 
(e.g. everyday) and a similar frequency of measures is not desirable; (c) the repeated measure is time 
consuming and administering it at each session would decrease the actual intervention time. 
Other measures in SCEDs 
Other measures used in SCEDs may include control variables, generalization measures, 
implementation data and standardized tests. 
(1) Control measures: these are measures evaluating untrained behaviors, that are not expected 
to change as a result of the implementation of the target intervention. Their stability after 
the implementation of the intervention shows that the patient is not making progress on the 
target behavior due to spontaneous recovery, practice effects, general stimulation, 
developmental maturation or time spent with therapist but due to the specific effect of the 
intervention on the target variable. Conversely, if the patient is making a spontaneous 
recovery or reacting to time spent with therapist, both the target behavior and the control 
measure are expected to show progress alike. Example of control measures include speech 
intelligibility in an intervention for dysphagia(22), naming of untrained words in an aphasia 
training(21), prospective memory tasks not prompted by the assistive technology being 
tested (23). 
 
(2) Generalization measures 
While it is important that an intervention shows a specific effect, the main quest for all 
rehabilitation programs is to improve patients beyond trained items, which is often called 
generalization. Generalization measures are increasingly recognized for their important role 
in contributing to the external validity of a study testing an intervention. Generalization 
measures assess the intervention’s effect on untrained tasks/items. These measures should 
be repeated but they do not have to be repeated as often as the target variable. There are 
four main timing options for assessing generalization (see table 4). Because the aim of 
rehabilitation is to improve daily life skills, a special effort should be taken to use outcome 
measures that are ecologically valid: this is true for the repeated measure but even more for 
the generalisation measure. It is not an issue specific to SCEDs, but a key issue in all 
rehabilitation research. 
 
INSERT TABLE 4 
 
(3) Implementation data demonstrates that implementing the intervention and progress of the 
patient go together. For example in Cosbey’s and Muldoon’s study(24), of a parent-delivered 
intervention at home for eating difficulties, the results graph shows that the progress in 
parents implementing the strategies at home corresponds with increasing effect on the 
child’s eating behavior. Implementation data is part of the broader concept of procedural 
fidelity, that is not specific to SCEDs but to which SCEDs give a major importance. This will be 
described later. 
(4) Other measures. Use of repeated measures does not preclude use of other measures that 
are not frequently repeated. Often, standardized, well recognized measures of known 
clinimetrics are used before and after the intervention (and if possible at follow-up) to show 
the effect of the intervention beyond the target variable, on a more general or well-known 
assessment tool. For example, in an intervention for sleep disorders after TBI(25), additional 
measures administered before and after the intervention included the Insomnia Severity 
index and the Dysfunctional Beliefs and Attitudes about Sleep scale. 
 
Different SCED designs 
In this section we aim at providing simple guidelines for beginners in SCED, but this is not a rule or 
recommendation.  
AB designs are not true SCEDs 
Before presenting the different types of SCEDs and their possible use, it should be emphasized that 
‘AB’ designs are not SCEDs. Often clinicians and researches may consider that they have used a 
SCED methodology when they apply an AB design, A corresponding to a series of repeated 
measure taken in baseline, (without intervention) and B a series of repeated measures in a B 
phase corresponding to an intervention. Although leading to a stronger evidence of treatment 
effects than pre/post designs where the patient is tested only once before and once after an 
intervention, the AB design still does not have sufficient control of biases to be considered a true 
experimental protocol(1,2). If a patient makes progress in phase B (as compared to phase A), this 
progress may be due to the intervention being tested but it may also be due to events occurring 
concurrently with the intervention, or just the passage of time, and causality cannot be 
differentiated from coincidence. The AB design is therefore NOT a true SCED(2), as reflected by 
the other name given to AB designs i.e. “pre-experimental” designs(4)). For this reason, its 
applicability is not presented here. In order to meet the standards of a SCED, the study must 
include at least three attempts to demonstrate an intervention effect (e.g. at least three phase 
change ABAB). ABA studies (two attempts to demonstrate treatment effect), however, are accepted 
as lower-standards SCEDs(2). 
 
Designs for interventions with on/off effects 
Introduction/withdrawal (ABA/ABAB designs) and alternating treatment designs require the 
intervention being tested to have immediate effects, short washout and on/off effects. Their use is 
particularly useful in (but not restricted to) rehabilitation to testing orthotics, prosthetics, use of 
drugs with on/off effects (e.g.: methylphenidate, intrathecal baclofen, anti-parkinsonian drugs), 
adaptive devices and assistive technology (contactors, vocal synthesizers, house automation, 
smartphones…).  
Alternating treatments designs consist of a rapid alternation between different treatments, typically 
changing intervention after a single administration. Figure 1 gives an example of easy-to-implement 
alternating treatment design that allows comparison of the effectiveness of three types of ankle foot 
orthosis on walking capacity of a hemiparetic patient. (26) The patient is coming every day to a 
physiotherapy session and with the three types of ankle foot orthoses at every session, the order of 
the conditions being changed (randomized) each day. Results are typically represented by joining the 
points of each condition together and showing that although the patients’ performance may be 
variable (due to fatigue, pain, motivation…), one condition shows a better effect that the other 
conditions. This design allows testing of more than two conditions at the same time (see (26,27) for 
examples of published SCEds using alternating treatment designs). If only two conditions are tested, 
the predictable pattern of administration, has been criticized and it has therefore been proposed 
that same conditions may be administered consecutively up to two times (see Onghena and 
Edgington(9) p58 for a demonstration). 
The introduction/withdrawal design, also called N of 1 trial in medicine, on the other hand, assumes 
that an intervention will be applied over a period of time (or in a number of sessions) and then 
withdrawn from the patient. For example in the ABAB study of Lui et al.(28) children with multiple 
disabilities were using a cord vibration switch (the “Hummer”) to play a picture matching game. 
Mean time per item and number of errors per session, were measured repeatedly across an A phase 
with a single output Hummer, alternating with a B phase using the novel dual-output Hummer.  
The simplest form of the introduction/withdrawal is the ABA design but the simplest design that 
meets the standards of showing at least 3 effects is the ABAB design (a graphical example is provided 
figure 2). However, more complex introduction/withdrawal designs, can be used, for example: 
-comparing effects of multiples interventions (e.g.. ABACADAEAF design in Tunnard and Wilson’s 
paper(29) testing 5 interventions for neglect)  
-varying the baseline condition, to simulate an intervention and obtain a patient blinding (e.g.: 
Sumitani et al who used an ABAA’CBAA’’B design for testing prism adaptation for chronic regional 
complex syndrome; A representing no intervention, A’ a neural prism and A’’ a 5° (i.e. insufficient to 
displace the visual field) prism- all As being variants of the baseline condition). 
-testing the combined use of two interventions(e.g.: ABACA(B°+C)A). 
 
If an introduction/withdrawal design is used on many patients, it is referred to as “Multiple N of 1 
trial”. This is typically the case when different patients alternate periods with a medicine and periods 
with a placebo, each period (=phase) typically lasting a few days or weeks. Figure 3 shows 
hypothetical data of study testing a sleeping drug in patients with sleeping disorder (but see also the 
published multiple N of 1 trial on central nervous system stimulant medication to treat acquired 
attention deficits in children with brain injury(30,31)). 
 
In rehabilitation, outside medications, adaptive devices and assistive technology, changes are usually 
slow and, they occur with a latency after the introduction of rehabilitation. Above all, a short wash-
out is not desirable as the aim of rehabilitation is to obtain long-term carry-over effects, maintained 
after the intervention is withdrawn. Therefore, in rehabilitation, another type of SCED is often more 
useful: the multiple baseline design. 
Designs for interventions with slow/delayed changes and no expected wash out 
In Multiple Baseline Designs (MBD), the intervention is introduced sequentially to different patients 
or settings or behaviours. MBD can be viewed as multiple AB designs, with as many AB designs as 
there are target patients, settings or behaviours. The evidence of such designs comes from 
demonstrating that change occurs when and only when the intervention is directed at that patient 
that setting or that behavior. Multiple baseline designs eliminate the need to return to baseline and 
therefore are particularly suited for evaluation of intervention with long-lasting effects, such as 
rehabilitation effects.  
The most used form of MBD is the MBD across patients/subjects: at least 3 subjects are needed. All 
begin the study with an A phase without any intervention (i.e. baseline), during which the target 
variable is measured repeatedly for each patient, until one of the patients starts the intervention, 
while the others continue without intervention, all patients still being measured repetitively on the 
target variable. Ideally, choosing which patients will begin the intervention and after how many 
baseline measures, should be determined via randomization procedure (this will be described later). 
The intervention is then applied to a second patient after a delay (again if possible determined via 
randomization) and finally to the third patient. MBD across patients are used in many domains of 
rehabilitation (25,32–35). The advantage of the sequential introduction of the intervention to is to 
visualize the lack of retest effect and lack of progress unrelated to intervention in the patients not 
having the intervention yet. This is the main reason that makes MBD across patients a stronger 
design than AB designs.  
Note that in MBD across subjects, each subject may follow a simple AB design but more complex 
designs (ABC, AB(B+C), ABCD…), in which different components of an intervention are tested 
separately or introduced sequentially (to explore their cumulative effect) to each patient are also 
possible (see figure 4 for an example).  
MBD across settings/contexts consists of implementing an intervention sequentially to different 
settings a patient operates in. A good example is Feeney’s paper(36) on context-sensitive routines at 
school for children with traumatic brain injury. The intervention consists of sending an outreach 
team to the school of the patients and coaching teachers to provide adequate, scaffolded support for 
the student’s executive functions. In this paper, the coaching is first introduced for the teacher of 
English, then after five sessions to the math teacher and finally five sessions later to the science 
teacher. Feeney shows that the pupil’s challenging behavior drops in intensity and in frequency when 
and only when the teacher has received the coaching and implements it in the classroom (while on 
the same days, challenging behavior remains high in classrooms where teachers had not received the 
training).  
MBD across behaviours, consist of applying an intervention (or slight variations of an intervention) to 
different target behaviours or goals or skills. For example:  
-introducing a proprioceptive training first to wrist flexion-extension and then to wrist ulnar/radial 
deviation (37) and measuring repeatedly the error degree in patient estimate of wrist position 
-proving reminders for memory problems for a patient’s goal one “remembering to take 
medication“, then to goal two “remembering to have lunch”, and finally to goal three “remembering 
to bring cell phone”(38) and measuring repeatedly the number of actions remembered for each of 
goal per week.  
-introducing an aphasia training first to verbs then to nouns (21) and measuring repeatedly how 
many nouns and verbs the patient names correctly from a list composed of verbs and nouns 
Note that the outcome measures in MBD across subjects belong to the same category (respectively 
in the above examples: wrist position estimate, actions remembered, words correctly named), but 
each behavior is measured separately (respectively position estimate for flexion/extension and for 
ulnar radial deviation separately, for each memory goal separately, for each category: noun and verb 
separately). 
The different types of MBD can be then combined together, which is called mixed MBD. Boman’s 
study(38) exploring home-based electronic memory aid for persons with memory impairments 
following brain injury, the design was a MBD across behaviours, (each behavior being one goal to 
remember every day, leading to a score of actions remembered out of seven each week), but it was 
applied to five different patients, thus combing it with a MBD across subjects. Similarly, Raymer’s 
study(21) of aphasia training across behaviours (nouns and verbs) was applied to eight participants. 
Other types of SCEDs 
Other types of SCEDs have been described such as the multiple probe, multiple treatment, 
concurrent schedule designs, most of them being variations of the above designs. They will not be 
described here but interested readers can refer to paper that listed these types of SCEDs (4,39) 
The changing criterion design or changing intensity design, where the patient enters a consecutive 
phase after s/he reached a predetermined level of performance (see examples(40–42)) is interesting 
in rehabilitation, especially when exploring intervention dosage and timings but its ability to establish 
causality has been questioned (1).  
Which SCED design to choose 
A simple decision tree of SCED design is presented in fig 5. In many cases, there are different design 
options possible to explore the same intervention.  
Planning the design 
Having decided on an outcome measure (target behavior) and the type of design to use, the third 
step consists of precisely planning the experiment, bearing in mind that, a high standard SCED design 
should include at least three attempts to demonstrate an intervention effect (i.e. at least 3 change 
phase in introduction withdrawal design, or at least 3 patients, 3 setting or 3 behaviours in MBD). 
Following the SCRIBE statement(19,43), each of the following should be decided prior to the 
beginning of the experiment and reported: 
-The type of design (e.g., withdrawal/reversal) 
-The number of phases (including baseline, experimental, maintenance and follow-up phases) 
-The order in which the phases are sequenced (e.g., randomized, counterbalanced, data-driven) 
-The number of sessions in each phase  
-The number of trials within each session in a phase (i.e., occasions when the outcome measure is 
being measured) 
-The duration of sessions 
-The time interval between sessions 
-If inclusions were concurrent (i.e. all subjects starting baseline at the same time), or non concurrent,  
Ideally, inclusion of patients, onset, and subsequent continuance, of data collection should occur 
concurrently in all patients (i.e., at the same points in time) i.e. concurrent inclusion. If recruitment 
does not allow to include 3 patients at the same time, it should be specified that inclusions (and data 
collection) were not concurrent. 
-The duration (length) of each phase (see table 5 for ways of deciding each phase length) 
 
INSERT TABLE 5 
It has historically been recommended to collect data in baseline until the patient stabilizes (i.e. 
response-guided determination of baseline length). In rehabilitation, this is rarely feasible or ethical 
because variability in performance is common for many reasons (due to pain, fatigue…) and trends 
(spontaneous recovery leading to progress in baseline) exist. Clinicians can choose baseline length, 
based on the following: (1) the more points in baseline, the more likely an intervention phase will be 
able to be differentiated from the baseline if an effect exists; (2) standards recommend at the very 
least three(44) but better five points(2,45) in baseline; (3) the greater the variability, the greater the 
need to have more than five points in baseline; (4) the greater the trend towards improvement, the 
harder it will be to show that the intervention has an additive effect to spontaneous recovery; (5) the 
smaller (more modest) the expected intervention effect, the greater the need to have more points in 
baseline. 
In general, using a response-guided determination of intervention phase length is preferable in a 
SCED aimed at piloting a novel intervention because the latency, variability and magnitude of 
outcome are usually unknown; both intervention and number of sessions needed may have to be 
adapted as the experiment runs. Randomized phase length, on the other hand, is preferable in later 
stages of development of an intervention, to prove its effectiveness or to conclude as to the best 
therapeutic option for a blinded patient.  
INSERT BOX 1 
Planning the implementation of the intervention 
While researchers primarily aim at demonstrating that an intervention is effective and recruit 
patients for that purpose (i.e. they will choose patients according to inclusion criteria tailored to who 
the intervention is likely to benefit), clinicians are most often faced with a patient needing an 
intervention and they adapt instead the intervention to the patient’s unique needs.  
 
One of the reported strengths of single-case methodology is the flexibility of implementation of the 
intervention(19) because the underlying goal of SCDs is most often to determine “Which intervention 
is effective for this case (or these cases)?”. Departing from initially planned protocol or intervention 
is allowed, as long as this is explained when reporting the results(19). The researcher may actively 
initiate changes that are a departure from protocol or they may be thrust upon the researcher as a 
result of external factors. If adverse events occur or the intervention is not working sufficiently, then 
it is acceptable for the researcher to make alterations without necessarily compromising 
experimental control. For example, if a participant is not responding to an intervention, then the 
intervention can be manipulated (adapted) while continuing to assess the target behavior (46). 
Because of the adaptive nature of SCD designs, non-responders might ultimately be considered 
“responders” under specific conditions that should be described, in order to allow other clinicians to 
know how to apply the intervention to particular patients.  
 
Treatment fidelity/procedural fidelity 
Treatment fidelity is the degree to which an intervention is implemented as planned. It helps to 
increase scientific confidence that the changes in the outcome measures are due to the intervention 
being tested.  
Treatment fidelity consists of two general components: 1) treatment integrity, the degree to which a 
treatment is implemented as intended, and 2) treatment differentiation, the degree to which two or 
more interventions or phases differ along critical dimensions. This means in SCEDs, that between 
baseline and intervention phases, everything but the intervention (as described in the protocol) 
should be kept constant. This means for example, keeping constant: time with therapist, quantity of 
positive feedback, environment, number of opportunities to carry out a task, family support… It 
means also describing precisely the content of the baseline (47), because the baseline condition may 
include important ingredients that influence the effectiveness of an intervention (e.g. patients taking 
a drug during baseline that influences response to a rehabilitation program or who stops a drug 
during a rehabilitation program confounding rehabilitation effects). 
Borelli described the importance of monitoring treatment fidelity in the following terms: “Without 
assessment of treatment fidelity, significant results may be a function of either an effective 
intervention or the influence of other unknown factors added into (or omitted from) the 
intervention. The danger of this is Type 1 error (belief that a treatment effect is significant when it is 
not) and the potential for dissemination of ineffective treatments. Similarly, if treatment fidelity is 
not measured and there are nonsignificant effects, it cannot be known whether these effects are due 
to an ineffective treatment or to the omission or addition of potentially active or inactive 
components. The danger of this is Type 2 error (erroneous belief that a treatment effect is non-
significant) and the potential for discarding effective treatments (2,6). Thus treatment fidelity 
enhances both the internal validity (the treatment is delivered as intended) and external validity (the 
treatment can be replicated and applied in real world settings)”. (p1)(48) 
Although the preoccupation of treatment fidelity is not specific to SCEDs (but should be essential in 
any trial testing an intervention), SCEDs have always put a strong emphasis on monitoring treatment 
fidelity. All SCED standards include the requirement to assess treatment fidelity and many ways exist 
to assess it(49–52). 
 
SCED quality appraisal tools and standards 
Reporting guidelines outline what to report in a SCED paper, in the same way as CONSORT(53) is a 
standard for reporting RCTs. The CENT reporting guidelines(54,55) are intended for medical N-of-1 
trials, the SCRIBE 2016 guidelines(19,43) are intended for SCEDs in the behavioral sciences (and 
largely used in neuropsychological rehabilitation). They can all be found on the Equator network 
(http://www.equator-network.org/) 
Other useful tools are scales appraising the quality of a SCED (see in particular the RoBiNT scale(2) 
that is a revision of the SCED scale(44)) and standards (see in particular the “What Works 
Clearinghouse -WWC standards of Kratochwill et al. (39,45) written for the field of education but 
widely used, including in rehabilitation studies). These document what constitutes a high quality 
SCED. To meet the standards in WWC, the following design criteria are required: (a) the intervention 
must have been systematically manipulated with the researcher determining when and how the 
intervention is implemented, (b) each outcome measure must be measured systematically over time 
and a measure of inter-rater reliability (IRR) for no less than 20% of sessions must be reported (c) the 
study must include at least three attempts to demonstrate an intervention effect (i.e. at least 3 
change phase in introduction withdrawal design, or at least 3 patients, 3 setting or 3 behaviours in 
MBD), and (d) for a phase to qualify as an attempt to demonstrate an intervention effect, the phase 
must have at least three (with a preference of at least five) data points. 
Other important recommendation include: (1) blinding of the patient and the assessor to the phase 
(which encourages that the repeated measure be performed by a person external to the therapist 
providing the intervention and knowing the phase the patient is currently at); (2) randomization (see 
box 1); (3) precise description of the intervention and assessment of procedural fidelity AND precise 
description of the baseline condition; (4) precise description of participants and of the setting of the 
study (5) a measure of generalization; (5) provision of raw data record and statistical analysis 
It is a sensible step in designing a SCED protocol, to go through these standards, and reporting 
guidelines (and perhaps use the RoBiNT scale to rate the intended protocol), in order to make 
adjustments before the study starts. 
Run the experiment 
We have presented the first five steps required to design a SCED, before running the study. These are 
summarized in table 6. After having made adjustments according to standards, the experiment may 
begin.  
INSERT TABLE 6 
As the experiment runs, the investigator should: 
-monitor unexpected events  
-keep information on any deviation or adaptation from original design and/or intervention content  
-evaluate procedural fidelity for a minimum of 20% sessions  
-do a double measure of the repeated outcome measure for at least 20% of measures in order to 
calculate the inter-rater reliability of the outcome measure. 
Note that it would be worth assessing these last two variables before the beginning of the 
experiment (as well as during the experiment), because a SCED that lacks adequate IRR or procedural 
fidelity will be unable to provide any conclusion as to the effectiveness of the intervention being 
tested. 
 
Representing the results- a few rules 
Because SCEDs are fundamentally different from traditional group research, SCEDs use specific rules 
in relation to reporting results.  
 
a) Results of a SCED are typically presented as a time series graph  
« The metric used on the horizontal axis of graphed data should be in units of real time (i.e., days, 
weeks, etc.) rather than session number. Providing an exact chronology of the time interval between 
sessions allows the reader to accurately evaluate patterns of consistency between similar phases and 
effect latency following intervention onset.” (p23)(19) 
Phase change/introduction of an intervention is typically presented as a vertical line.  
In multiple baseline designs, if the inclusion of participants was not concurrent (i.e. patients included 
at different times), it is better representing the time frames between patient inclusions. 
 
b) Results should not be averaged 
Averaging means that important features of data may be lost, such as (a) stability of the initial 
baseline phase, (b) variability and trends within a phase, (c) degree of consistency between similar 
phases (e.g., intervention phases), (d) the degree of overlap between baseline and intervention 
phases, (e) magnitude of effect latency following intervention phase onset.  
c) Visual aids for graph interpretation may be represented on the graph to help visual 
interpretation. Note that visual aids are drawn separately for each AB comparison (so for 
example in a MBD across subjects, the data of each subject will be analysed separately) 
 
d) Statistical analysis should never standalone (as is usually the case in group studies) but 
should follow the graph and be interpreted in conjunction with the visual analysis of the 
graph.  
 
Visual interpretation of SCED data 
Historically, SCED data was interpreted only visually. Visual analysis aids useful in rehabilitation 
studies include: 
-level lines (see figure 6a), corresponding to the median or mean of all data points of one phase, that 
allows to compare change in levels between phases. This is more useful in interventions with on/off 
effects because in interventions showing slow changes, the first measures of the intervention phase 
(when the intervention was not effective yet), may lower the level of intervention phase. 
-trend lines (see figure 6b and 6c) i.e. the tendency of data point to go upwards or downwards 
within a phase. This is a key analysis in rehabilitation as patients are often not stable within a phase, 
but show trend towards improvement (e.g. in the acute phase post stroke) or towards decline (e.g. 
degenerative disease). Trend lines can be used to project baseline trend into the intervention phase 
allowing visualization of whether the trend continues the same (reflecting a progress likely to be due 
to the follow-up of spontaneous recovery seen in baseline and unlikely to be an intervention effect) 
or accelerates (reflecting an intervention effect). A trend may be more or less obvious and it has 
been proposed that trend lines can be considered representative of the data within a phase only if 
80% of the data fall into the trend line envelope (56), see figure 6c. The trend of a phase can by 
drawn by hand, using the split-middle trend line – a line joining the median (or alternatively the 
mean) of each half phase (see appendix 1 in e-component). 
Trend lines and level lines have been combined by Fisher(57) in his « dual criterion method ». In this 
method, one first calculates the baseline level (mean line based on baseline data) and then 
superimposes it over the subsequent data path. Next, a split-middle trend line is calculated based on 
baseline data and extended into the subsequent phase. An effect (i.e., a change in data across 
phases) is said to exist when a prespecified number of data points have fallen above each of the lines 
according to a binomial equation. Fisher et al. demonstrated that the dual criterion method generally 
resulted in fewer Type I errors.  
-variability bands, correspond to the spread of data points within a phase, and whatever the design, 
the smaller the variability within a phase, the easier to detect an intervention effect. The most used 
variability technique is the two-standard deviation band(17,58), drawn by calculating the mean of a 
phase and adding and subtracting 2 standard deviation (taking the standard deviation of the studied 
phase only) from it (17); see figure 6d. 
-overlap is the calculation of points overlapping between phases: the more overlap between two 
phases, the less likely an intervention effect exists. Conversely, if two phases show no overlap in the 
measures, the intervention is likely to have an effect of greater magnitude. Many overlap techniques 
exist, from simple hand calculation, often used in the history of SCEDs but highly criticised (percent of 
phase B data points which exceed the single highest phase A data point ; percentage of phase B data 
points exceeding the median of the baseline phase (PEM); percent of all data remaining after 
removing the minimum number of data points which would eliminate all data overlap between 
phases A and B ; …(59)) to more complex calculations of overlap such as “Non-overlap of all pairs -
NAP”(59), Tau-U and baseline-corrected Tau-U(60) (that can be calculated from : 
http://ktarlow.com/stats/tau/). This last measure of overlap is probably the most useful in 
rehabilitation studies as it calculates overlap even in highly variable data, correcting for trend.  
Most visual analysis aids can be drawn by hand (see tutorials on visual aids: What Works Clearinghouse 
(p17-21), Perdices and Tate (17), Lane and Gast(56)), but useful web-based resources allow 
computation by entering data in a text format (see especially the user-friendly website 
https://manolov.shinyapps.io/Overlap).  
Systematic visual analysis has shown to increase the accuracy of interpretation of SCED data, 
especially in relation to the conservative dual criterion (57), as shown in several studies(61–63). 
Some of the visual analysis criteria used in behavioral sciences (39), such as consistency across phase, 
immediacy of effect, coherence of measures within a phase are not always appropriate for SCEDs in 
rehabilitation because effects in rehabilitation are rarely immediate, and measures within a phase 
often variable (due to fatigue, pain, spontaneous recovery…). 
 
Statistical interpretation of results 
Many statistical procedures for interpreting SCED data exist and there is dynamic ongoing research 
on statistical analysis of SCED data. There is no consensus on which statistical procedure to choose to 
analyse SCED data (2,12,43,64). Providing clinicians with statistical methods to interpret SCED data is 
beyond the scope of this paper. Interested readers are referred to the SCBIBE appendix(19) for the 
available statistics for SCED, to Manolov et al(64) discussion on criteria for choosing a statistical 
procedure and to Manolov and Moeyaert’s recommendations and practical statistical computing 
tutorials (65,66).  
 
Specific issues in interpreting SCED data 
When interpreting SCED results, the following should be kept in mind: 
-Visual analysis may be quite subjective, which can lead to increases in type 1 errors (estimated in 
several studies to be 0.24-0.28), especially when a trend exists and when analysis is done without an 
adequate visual analysis training (67). 
-SCED data are usually autocorrelated (68) (because the behavior of a subject is rarely random) which 
violates the assumption of most statistical tests. Matyas and Greenwood estimated type 1 error 
(concluding that an intervention has an effect when it does not) rates at 0.24 on data when 
autocorrelated.  
-Reliability in measuring the outcome measure is crucial for SCED interpretation. Beside the problem 
of choosing an outcome that is easily measurable, the fact that the measure is repeated many times 
may make it less reliable because of a) possible retest effect; b) observer drift (possibility that 
observers may change their observational definitions of the construct being measured over time, 
thereby not making scores comparable across phases of the experiment); c) observational bias 
(possibility that observers may be influenced by a variety of factors associated with desired 
experimental outcomes); d) reactivity (possibility that observational scores are higher as a result of 
the researcher monitoring the observers or observational process). Reporting the IRR and blinding 
the observer to the treatment phase are crucial to avoid those biases, especially if the outcome 
measure seems subjective (e.g. in Logan’s study assessing “happiness” - a highly subjective construct-
in children with multiple profound disabilities across different teaching conditions, happiness ratings 
were based on video-taped sessions visualized in random order by a blinded judge and rated on 
specific criteria pre-determined and specific for each child (27)). 
The issue of replication and generalizability of findings 
The concept of applicability or generality is based on the assumption that inferences can be drawn 
from the condition in which an intervention effect was demonstrated, to other conditions based on 
known similarities and differences between these conditions(69). 
 
A major criticism of SCEDs is that the findings cannot be generalized to other patients and that 
demonstrating an effect on three patients is not a proof of intervention effectiveness beyond those 
particular patients. To emphasise this, abstracts sometimes end with “These results cannot be 
generalized beyond the patients included in these trials.”(70) 
We argue however, as many other methodological papers, that this issue is not specific to SCEDs. 
RCTs report group means that mask the differential responses to treatments(1). “Even in the most 
successful group design, there are individuals whose behavior remains unaffected , or is made worse, 
by the treatment” (p173)(46). Besides RCTs often use very restrictive inclusion criteria that makes the 
results difficult to apply to “the messy complexities of clinical problems”(71) » (16)(p2) and their 
generalizability may therefore be poor. Further, many interventions, tested through group designs, 
have never been able to be replicated(72). In rehabilitation, we are used to adapting rehabilitation 
techniques, devices and assistive technology, based on the patient’s characteristics, personal and 
environmental factors(73). In the age of personalized medicine, it seems almost unthinkable to apply 
blindly the result of an RCT to all patients. 
Although, just like RCTs, SCED cannot prove that an intervention will work for all patients, there are 
ways to increase the generalizability of SCED findings. 
a) The first way is replication. As mentioned earlier, the highest SCED standards require that the 
experimental effect be replicated at least three times within the SCED study(2,45,46). This 
type of replication increases the internal validity of the SCED design and is known as direct 
replication (9,19). It refers to the replication of the experimental effect within the design. 
Therefore, SCEDs using ABA designs, or MBD across 2 patients/settings/behaviours do not 
fulfil the replication criterion. 
The second type of replication is replicating the whole SCED, with the same intervention but 
with other patients, settings, clinicians (also called systematic replication(9,19)).Each replication will 
add information regarding the generalizability of the findings. For example, Feeney and Ylvisaker 
(74,75,36)replicated across different students with TBI and across different schools their intervention 
for executive dysfunction first published by Feeney(76). 
A number of studies meta-analysing SCEDs have been published(77–81) and contribute to 
establishing the evidence acquired from use of SCEDs. For example, Moss and Nicholas used data 
from 23 SCEDS, comprising a total of 57 subjects and show that for patients more than one year post 
onset of aphasia, time post onset is not related to response to treatment.  
 
b) The second way that generalisability is increased is by the precise description of patient’s 
characteristics, history, associated deficits etc., to allow those reading the paper to apply the 
findings to similar patients.  
 
c) The third complementary way is the assessment of “social validity”. Social validity reflects 
contextual aspects that will influence the replication and/or the use of the intervention in the 
real world and that might augment or inhibit the effectiveness of an intervention. These 
aspects include: (a) whether the treatment was easy or difficult to implement, (b) whether 
any unintended consequences developed in conjunction with the intervention, or (c)whether 
the interventionist will continue or expand the use of the treatment and why. The reporting 
of social validity data is useful for identifying contextual trends 
 
When can we consider an intervention as effective using SCEDs? 
A number of criteria have been established. These criteria relate to two main issues: (1) the quality of 
SCED research taken in consideration; (2) the quantity of replication (an intervention being more 
likely effective, if it has been replicated many times). Regarding the first criteria, standards exist that 
allow clinicians to evaluate the studies methodological qualities(2,45) (see paragraph on standards) 
and just like in group studies, only methodologically sound studies should be considered as evidence 
to implement an intervention in routine clinical practice. Logan et al.(82) proposed a grading of levels 
of evidence for SCEDs, based on the SCED design type, the use of randomization, the number of 
direct replication. The second issue relates to the amount of replication needed to have confidence 
that the intervention effect will be present in everyday clinical practice. Although this is a ‘rule of 
thumb’, the 5-3-20 rule has been proposed by What works Clearinghouse : a minimum of five SCD 
research papers examining the intervention that meet quality standards, conducted by at least three 
different research teams in three different geographical locations with a combined number of 20 




Challenges and prospects for SCEDs 
Most papers using SCED appear to evaluate cognitive interventions (although this may be a search 
bias as traditionally SCED methodologies have been used in neuropsychology and education with 
clear references to SCED in the title/abstract, whereas papers from other domains do not always 
used “SCED” methodology key words in pubmed). We argue that SCEDs are a useful tool in areas 
outside neuropsychological rehabilitation in PMR and would be helpful if applied to motor 
interventions, therapeutic education, adaptive devices and assistive technology choices etc. 
If we are to increase the use of well-designed SCEDs in rehabilitation we suggest that it is necessary 
to: (1) Provide appropriate teaching on SCEDs to students of all rehabilitation fields. (2) Convince 
journal editors and funding institution that SCEDs are not case reports but high-quality research. For 
example, a SCED should not appear under “case report” section of journals, because they are 
fundamentally different from retrospectively reporting a case. (3) SCED protocols should be entitled 
to be published as preregistered trials (note this is beginning slowly, especially in N of 1 trails, see for 
example(30)). (4) Endorse reporting guidelines such as SCRIBE or CENT to standardize the reporting 
of SCEDs in PRM journals. (5) Encourage and support students to use SCED methodologies for their 
degree thesis, rather than poorly designed group studies, lacking power or descriptive case reports or 
retrospective data analysis. 
The best opportunity for PRM research is perhaps not to increase the number of large scale studies, 
using group designs, but make the most of the small scale research done routinely in all 
rehabilitation centres, hospitals and private practices by rehabilitation students and professionals. 
Such “small” scale research often uses an inadequate methodology, while the same amount of work 
could yield a robust SCED. For example, students often use small groups tested pre-and post-
intervention, whilst including just three patients but using a multiple baseline design could give 
stronger evidence of the intervention being tested. Another advantage is to have the student entirely 
responsible for his/her protocol, rather than joining ongoing research. This could hopefully result in 
acquiring better scientific reasoning than just performing a protocol. Another opportunity is to use 
multicentre SCEDs, for example creating collaborations between two PRM students for testing the 
same intervention in two different cities, using SCEDs: this type of design is easy to complete within 
an academic year (for example including two patients per student). Having pairs of students allows 
them to measure the IRR and procedural fidelity for 20% of sessions as recommended in standards.  
Conclusion 
SCEDs offer an opportunity to conduct high quality research with a limited number of patients, to 
evaluate the effects of intervention for patients individually and to explore the effectiveness of novel 
approaches devised by local therapists outside the world of research. 
SCEDs follow a series of rules for designing the experiment and interpreting data, but greater 
awareness of, and skills in, this methodology are needed. Following the steps described in this paper 
or other tutorials may be a first step for clinicians to use SCEDs.  
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Table 1: Different names give to SCEDs  
Different names given to SCEDs Different types of SCEDs 
Single Case Experimental designs (SCED) 
 
Single Subject Experimental designs 
(SSED) 
 








Single-Case Design (SCD) 
 
Single-Systems designs 









Mixed multiple baseline design 
 
Alternating treatment design 
 
Changing criterion design 
 
Changing Intensity design (1) 
* N of 1 trial is the term usually used for SCED in medicine (research on drugs 
using single cases especially). Although the term “N of 1 trial” is sometimes used 
for different types of SCEDs, Guyatt et al. (3) have proposed to limit the term N of 
1 trial to introduction/withdrawal designs i.e. ABAB designs with multiple cross-
overs, blinding of patient and therapist, and randomization.  
 
 
1. Graham, J. E., Karmarkar, A. M. & Ottenbacher, K. J. Small Sample Research Designs for Evidence-
Based Rehabilitation: Issues and Methods. Arch. Phys. Med. Rehabil. 93, S111–S116 (2012). 




Table 2: Differences in outcome measures between group studies and SCEDs 
Traditional Group Research 
 
SCEDS 
Use of validated measurement tools with 
known psychometrics/clinimetrics, especially 
interrater reliability 
 
Measurement is repeated not more than two or 
three times (before, after and at follow-up) 
 
Create your own outcome measure* 
Corresponding to an objective and measurable 
behavior 
That can be repeated in time (without major 
practice effect)** 
Need to examine and report its reliability in 
your SCED paper 
Relatively short to administer, as administration 
will be repetitive 
Sensitive to change/with good 
responsiveness*** 
 
* the repeated measure can, however be a validated test as long as it can be repeated without 
major retest effect, and is not too long to administer. For example, Gharebaghy et al. (19) used a 
standardized measure of motor skills, repeated 14 times, to assess the effectiveness of a CO-OP 
(Cognitive Orientation to Occupational Performance) intervention in children, Nikles et al.(20) used 
the Conners questionnaires for parents and teachers (assessing attention problems experimented 
by children at school and at home) to assess the effectiveness of methylphenidate after brain 
injury .  
**the repeated measure can also use many parallel forms of a task to avoid the retest effect (see 
for example McKerracher et al. (21)), although this faces the additional requirement of having 
parallel forms with the same difficulty level. 




1. Gharebaghy, S., Rassafiani, M. & Cameron, D. Effect of Cognitive Intervention on Children with 
ADHD. Phys. Occup. Ther. Pediatr. 35, 13–23 (2015). 
2. Nikles, C. J. et al. Aggregated n-of-1 trials of central nervous system stimulants versus placebo for 
paediatric traumatic brain injury–a pilot study. Trials 15, 1 (2014). 
3. McKerracher, G., Powell, T. & Oyebode, J. A single case experimental design comparing two 
memory notebook formats for a man with memory problems caused by traumatic brain injury. 
Neuropsychol. Rehabil. 15, 115–128 (2005). 
 
  
Table 3: Examples of repeated measures used in rehabilitation SCEDs 
Example of study Repeated measure/Target behavior 
Constraint-induced movement 
therapy for a baby(23). 
Videotaped analysis of the number of times the baby reached 
for an object, stabilized weight and approached midline with 
affected limb. 
Comparing two types of memory 
book(21) 
Number of prospective tasks completed each week. 
Prospective memory tasks chosen were things that could be 
verified by a member of staff at the rehabilitation centre (e.g., 
telephone key worker on Tuesday by 3.30, bring letter in on 
Wednesday for the occupational therapist). The types of tasks 
or themes remained the same each week, although the details 
varied, in order to have eight sets of 
tasks that were parallel. 
Strength and Proprioceptive 
Training Program  after ankle 
sprains(24) 
Number of times a balance board made contact with the floor. 
Web-based navigation system for 
topographical disorientation 
following brain injury(25) 
Mean navigation errors per route, fifteen route pairs were 
identified (e.g., OT to PT, ST to OT), any of which, in varying 
orders, the participant might follow on a particular therapy 
day. 
Use of Ultrasound feedback in 
dysphagia rehabilitation(26) 
Frequency of observed anterior spillage, of observed 
penetration-aspiration signs and of swallows self-initiated. 
Semantic-phonologic treatment 
for noun and verb retrieval(27) 
Number of nouns and verbs correctly named, including trained 
and untrained noun and verb lists 
Evaluation of a thumb opens 
splint on hand function in 
cerebral palsy(28) 
Use of Goal Attainment Scales (i.e. patient-specific goals rated 
on a scale between -2 and +2) 
Treatment of Insomnia 
associated with traumatic brain 
injury(29) 
Daily diary reports of total wake time 
Dressing disability after 
stroke(30) 
6-point rating from the shirt section of the 
Nottingham Stroke Dressing Assessment (selects 
correct hole for paretic arm; pulls over paretic elbow; selects 
correct hole for 
non-paretic arm; pulls over elbow; pulls overhead; pulls down 
AND time needed to dress) 
Use of Google Calendar for 
severe memory 
problems(31) 
Number of target actions remembered to perform among 
patient chosen goals (attending the mosque, attending 
rehabilitation activities and going to medical appointments). 
Impact of typical peer 
interactions in children with 
severe profound multi 
disabilities(32) 
Happiness behavior, defined pre-intervention individually for 
each child, presented on 10-seconds video sequences to an 
external judge in a random order 
Location-based prompting for 
working activity for individuals 
with cognitive impairments(33) 
Percentage of correct task steps completing snack orders 
Non-pharmacological 
multidisciplinary 
care programme for persons with 
generalised osteoarthritis(34) 
Diary measures for self-efficacy and VAS for pain 
Use of smartphones for severely Number of programmed phone calls made on time 
dysexecuitve patients (35)  
Relearning of daily living routines 
(morning self-care and diabetes 
management) for a woman with 
impaired memory and initiation 
following haemorrhagic stroke 
(36) 
Percentage of the steps in each of the two routines completed 
independently (extensive precise list of the steps of both 
routines provided in the paper) 
Intervention for executive 
dysfunction and prospective 
memory in children(37) 
“Saint Day task”: punctuality score in sending the investigator 
the saint day name at predetermined time by text message, e 
mail or phone call 
Management by fathers with ABI 
of oppositional behavior in their 
children (38) 
Number of requests the child responds to chosen from a list of 
problematic behaviours tested pre intervention 
Interactive Web-based 
cueing, to provide guidance for 
alarm clock setting(25) 
Number of activity steps attempted 
OT: occupational therapist; PT: physiotherapist; ST: speech therapist; ABI: acquired brain injury 
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Table 4: Possible timings for assessing generalization 
Timing for assessing 
generalization 
Examples of generalization measures: 
(1) measured at the same 
frequency as the main 
outcome measure. 
Tiredness using a 5-point modified Borg scale, after a session 
using a novel dual-input switch(39) (the main repeated 
measures assessed the patient’s speed and accuracy in using 
the switch but it was expected to decrease patient’s 
tiredness) 
 
Percentage of completed work at school, after an intervention 
for executive dysfunction following brain injury targeting 
challenging behavior (40) 
 
(2)”probed continuously” 
(i.e. measured repeatedly 
but not as frequently as 
the main outcome 
measure)  
Recommended by SCRIBE(22), but no examples could be 
found in the field of rehabilitation 
(3) measured at the end 
of the intervention.  
 
After an intervention teaching fathers with brain injuries to 
manage their uninjured children on a series of trained 
tasks(38), untrained tasks were used at the end of the 
intervention to evaluate if fathers could apply the strategies 
with their child in new situations 
(4) measured pre/post 
intervention 
Attainment of personal goals on Goal Attainment Scales, 
following CO-OP (“Cognitive Orientation to Daily Occupational 
Performance”); intervention in children (the main repeated 
measure assessed global motor skill acquisition but this was 
expected to generalize to personal goals)(19) 
 
Multidimensional Fatigue Inventory, Beck Depression 
Inventory and Beck Anxiety Inventory; following a cognitive-
behavioral sleep intervention for insomnia post brain 
injury(29) (the improvement on the main outcome measure - 
the total wake time, was expected to reduce daytime 
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Table 5: Possible ways for determining the length of each phase 
 
Proportional Having in mind the time constraints for the study (e.g.: to be completed within 
12 weeks) and the number of phases (e.g. ABAB = 4 phases), duration of each 
phase is calculated to have the same length for each phase (3 weeks each in 
this example).  
Response-
guided 
In a response-guided design, the phase length depends on the emerging data. 
For example, a researcher who intervenes only after baseline data have 
stabilized is using a response-guided design. A researcher who waits until a 
participant treated reaches a certain level of performance in the first setting 
before intervening in the second setting is also using a response-guided 
design(50) 
Randomized 
(see Box 1) 
Phase length is determined at random, by a randomisation procedure, often 
using software (e.g. R program, with SCDA plugin) 
Restricted 
randomization 
Very often, due to constraints that can be either clinical (duration of hospital 
rehabilitation), academic (study to perform in a set amount of time for a 
student) or financial (funding for a set amount if session/ rental of equipment), 
SCEDs have to be completed in a set amount of time. Planning of the design will 
depend on the frequency of intervention sessions, the total time required for 
the intervention. 
Phase length may then be determined at random, but within pre-specified 
requirements (e.g. need to have at least five measures per phase) and 
constraints (e.g. total duration of the study, with all phases, to be kept under 16 





This solution has been proposed to increase the study validity when response -
guided designs are used, because in response guided design the risk is to bias 
the study by introducing the intervention when the experimenter thinks the 
intervention has the best probability to work (which increases type 1 error).  
It uses random assignment of participants to intervention times and a data 
analyst who is blind to which participants enter treatment at which points in 




1. Ferron, J. & Jones, P. K. Tests for the Visual Analysis of Response-Guided Multiple-Baseline Data. 
J. Exp. Educ. 75, 66–81 (2006). 
 
  
Table 6: Steps for designing and running a SCED 
Step 1 Find an outcome measure that can be repeated 
many times throughout the experiment, 
without major retest effect, that is relatively 
short to administer and that reflects 
intervention target 
See table 2 and 3 
Step 2 Choose any other outcome measures to be 
used (control measures, generalisation 
measures, implementation measures, other 
standardized measures) 
See table 4 
Step 3 Choose a design See figure 5 
Step 4 Plan design details +/-randomisation See table 5 and box 1 
Step 5 Adapt/describe intervention details and choose 
a measure of procedural fidelity 
 
Step 6 Review protocol according to standards  
Step 7 Run the experiment, monitoring unexpected 
events, keeping information on any deviation 
or adaptation from original design and/or 
intervention content, evaluating procedural 
fidelity, and assessing IRR of the outcome 
measure 
Keep in mind that in SCEDs at least 
three measures will need to be 
reported: 
-a graph with the main repeated 
outcome measure across phases 
-the IRR of the main outcome 
measure 
-a measure of procedural fidelity 
 
Step 8 Plot and analyse data visually An aid for plotting data and 
performing visual analysis aids can 
be found at 
https://manolov.shinyapps.io/overlap 
Step 9 Use statistics to confirm visual analysis   
IRR: inter-rater reliability 
 
  
 Box 1: Randomization  
In group studies, randomization exclusively refers to allocation of participants to intervention groups 
(i.e. experimental vs. control). By contrast, in SCEDs, a number of design elements can be 
randomized: (a) the baseline and each phase length (number of measures in each phase) ; (b) the 
order of introduction of intervention to different  subjects, setting, behaviours in multiple baselines, 
(c) the order of each condition in alternating treatments. 
There are two main advantages of randomization: 
-Using randomization allows interpretation of SCED data using randomisation tests(1). 
Randomization tests are permutation test based on random assignment to test a null hypothesis. 
This means that in order to work, there must be a sufficient number of possible assignments. In an 
AB design this is a minimum of 25 measures (2 phases combined) to allow 20 different intervention 
starting points, (with a minimum 3 points per phase). In a MBD across three subjects, it is enough to 
have 11 measurements per subject. Note that for a MBD the data of all subjects is used together and 
a single p value is obtained for all the subjects (or contexts or behaviours) the MBD entails. Different 
ways of performing a randomization test exist for MBD (2). When designs do not contain 
randomization, the ability of randomization tests to control Type I error rates can no longer be 
demonstrated mathematically(3).  
 
-Using randomization increases the internal validity of the study and scientific credibility (4), in the 
same way as randomization increases the internal validity of a group controlled trial. A randomized 
experiment, is in many respects to be preferred to a nonrandomized or quasi-experiment because of 
the statistical control over potential unknown confounding variables related to time (e.g., history, 
maturation, spontaneous recovery etc.) the participants, or the setting (5).  
 
In a nonrandomized intervention study, one usually has no control over the variables that covary 
with the intervention (e.g. change in patient’s medication, life stressors, pain etc.) or with the 
decision to intervene (e.g. bias by beginning the intervention when the patient seems most 
motivated), making it very difficult to avoid response-guidance biases or regression artefacts (5). 
 
1.  Heyvaert M, Onghena P. Analysis of single-case data: Randomisation tests for measures of effect 
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3.  Ferron J, Foster-Johnson L, Kromrey JD. The Functioning of Single-Case Randomization Tests With 
and Without Random Assignment. J Exp Educ. 1 janv 2003;71(3):267‑ 88.  
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J Pain. févr 2005;21(1):56-68; discussion 69-72.  
 
  
Box 2: example of design choice, following SCRIBE design details, using restricted randomisation 
Example: planning the design for a speech therapy intervention for patients with aphasia. 
Intervention: gesture either through classical therapist guided session or using mute films. 
Outcome measure: number of words correctly signed and named from a list of 40 words the 
patient cannot name or gesture.  
Design: Multiple baseline across subjects 
Timing requirements: Intervention to be completed in a 12 weeks period. Patients seen 5 times a 
week in stroke rehabilitation centre. 
SCRIBE design detail Application to the example 
The type of design Multiple baseline (because a maintenance of effect is desirable and 
expected) 
 
Across five patients (to meet the standard of at least 3 demonstrations of 
effects, taking into account possible loss to follow-up: possible 
premature return home or difficulty in maintaining the program 
intensity) 





Baseline (A) with no intervention (during which an extensive aphasia 
evaluation will be performed) 
Intervention 1: mute films (phase B) 
Intervention 2: gesture therapy (phase C) 
Follow-up phase (without intervention) 
 
The duration (length) 
of each phase 
2 weeks minimum (because interventions 1 and 2 are unlikely to be 
beneficial if length <10 sessions) 
The number of 
sessions in each phase 
Five days a week program, so a minimum of 2x 5 = 10 sessions per 
intervention phase 
The number of trials 
within each session in 
a phase (i.e., occasions 
when the dependent 
variable is being 
measured) 
Because of intervention intensity and the duration of administration of 
the repeated measure (10 minutes), it was decided to administer the 
measure at every other session. * 
The order in which the 





Restricted randomization in order to have at least five measures per 
phase and a minimum of two weeks of each intervention.  
The duration of 
sessions 
45 minutes 
The time interval 
between sessions 
One session a day from Monday to Friday, no intervention during week-
end 
* it would be convenient to acquire the 5 points in baseline using measures every session, but the 
frequency of repeated measures in baseline and intervention has to be the same. 
 
Example of calculation of phase length randomisation restrictions: 
-Calculation of the minimum time required to complete all phases of the design: Minimum of 5 
measures per phase= 5 (baseline) +5 (intervention 1) +5 (intervention 2) = 15 measures, = 30 
sessions (because one measure is taken every two sessions =6 weeks minimum to complete the 
whole design if all phases are the same proportional and minimum length. 
-Total available time for the experiment: 12 weeks.  
 
-Introduction of intervention can therefore be staggered for 5 different patients i.e. intervention 
starting after 5, 6,7,8,9 or 10 measures (so 10 to 20 sessions i.e. 2 to 4 weeks of baseline) i.e. 
randomizing which patient starts intervention first, within the limit of starting between 5 and 10 
measures.  
-Baseline is followed by an intervention 1 phase of randomized length with a minimum of 5 
measures (i.e. 10 sessions = 2 weeks of intervention) in the phase. Patients switch to the second 
intervention after 5, 6,7,8,9 or 10 measures (so after 10 to 20 sessions i.e. 2 to 4 weeks of 
intervention 1). 
 
-Order of interventions (Intervention 1 =mute films; Intervention 2 = gesture therapy) can also be 
randomized.   
 
This design will allow to use a randomization test to interpret data. 
 
 





  
